Results 81 to 90 of about 6,202 (205)

99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients : a biodistribution and dosimetry study [PDF]

open access: yes, 2016
Background: Biologicals directed against tumour necrosis factor (TNF) have proven their efficacy in the treatment of spondyloarthritis and rheumatoid arthritis.
Bacher, Klaus   +9 more
core   +2 more sources

THE USE OF VIRTUAL REALITY FOR TRAINING PROFESSIONALS OF NUCLEAR MEDICINE [PDF]

open access: yes
The use of virtual reality has becoming an important tool for training purposes, with emphasis to those procedures that involve risk to professionals, as those associated with occupational exposure to ionizing radiation in nuclear medicine services ...
CARVALHO, Juliane S.   +5 more
core  

Regulatory Requirements for Small-Scale Preparation of Radiopharmaceuticals

open access: yesРегуляторные исследования и экспертиза лекарственных средств
INTRODUCTION. The concept of pharmacy preparation of radiopharmaceuticals (RPs) was first introduced in Russia with the entry into force of the Federal Law No. 61-FZ “On Circulation of Medicines” of 12 April 2010.
G. E. Kodina   +8 more
doaj   +1 more source

Biological Assessment of a 18F-Labeled Sulforhodamine 101 in a Mouse Model of Alzheimer’s Disease as a Potential Astrocytosis Marker

open access: yesFrontiers in Neuroscience, 2019
Neurodegenerative diseases have mainly been associated with neuronal death. Recent investigations have shown that astroglia may modulate neuroinflammation in the early and late stages of the disease.
Ingrid Kreimerman   +9 more
doaj   +1 more source

To serve and protect: Enzyme inhibitors as radiopeptide escorts promote tumor targeting [PDF]

open access: yes, 2014
Radiolabeled octreotide analogs are most successfully being applied today in clinical cancer imaging and treatment. Propagation of this paradigm to other radiopeptide families has been greatly hampered by the inherent poor metabolic stability of ...
Jong, M. (Marcel) de   +3 more
core   +2 more sources

Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [111In-DOTA]MG11 [PDF]

open access: yes, 2016
Background: We have recently shown that treatment of mice with the neutral endopeptidase (NEP) inhibitor phosphoramidon (PA) improves the bioavailability and tumor uptake of biodegradable radiopeptides.
Jong, M. (Marion) de   +6 more
core   +5 more sources

Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair

open access: yesMolecules, 2019
Background: The GRPR-antagonist 68Ga-SB3 visualized prostate cancer lesions in animal models and in patients. Switching radiometal from 68Ga to 111In impaired tumor targeting in mice, but coinjection of the neprilysin (NEP)-inhibitor phosphoramidon (PA ...
Emmanouil Lymperis   +6 more
doaj   +1 more source

Relationship between primary liver hepatocellular carcinoma volumes on portal-venous phase CT imaging [PDF]

open access: yes, 2016
The liver is an important organ in the body. It is located under the rib cage on the right side. The liver performs many important functions, it processes food for nutrients that the body requires and also helps in the detoxification of harmful materials.
Aisaborhale, Ehimen Edward
core   +1 more source

EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging Study [PDF]

open access: yes, 2015
Noninvasive imaging is a critical technology for diagnosis, classification, and subsequent treatment planning for patients with glioblastoma. It has been shown that the EphA2 receptor tyrosine kinase (RTK) is overexpressed in a number of tumors ...
Boyd, Andrew W.   +11 more
core   +2 more sources

The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: A clinical phase II study [PDF]

open access: yes, 2017
Purpose: The aim of this phase II study was to evaluate the tumour response of neuroendocrine tumours to targeted irradiation with the radiolabelled somatostatin analogue 90Y-DOTATOC.
Haldemann, A.   +4 more
core  

Home - About - Disclaimer - Privacy